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ABSTRACT We conducted a deletion analysis of two regions identified in the II-III loop of 1S, residues 671–690, which were
shown to bind to ryanodine receptor type 1 (RyR1) and stimulate RyR1 channels in vitro, and residues 720–765 or the
narrower 724–743 region, which confer excitation-contraction (EC) coupling function to chimeric dihydropyridine receptors
(DHPRs). Deletion mutants were expressed in dysgenic 1S-null myotubes and analyzed by voltage-clamp and confocal
fluo-4 fluorescence. Immunostaining of the mutant subunits using an N-terminus tag revealed abundant protein expression
in all cases. Furthermore, the maximum recovered charge movement density was 80% of that recovered by full-length 1S
in all cases. 671–690 had no effect on the magnitude of voltage-evoked Ca2 transients or the L-type Ca2 current density.
In contrast, 720–765 or 724–743 abolished Ca2 transients entirely, and L-type Ca2 current was reduced or absent.
Surprisingly, Ca2 transients and Ca2 currents of a moderate magnitude were recovered by the double deletion mutant
671–690/720–765. A simple explanation for this result is that 720–765 induces a conformation change that disrupts EC
coupling, and this conformational change is partially reverted by 671–690. To test for Ca2-entry independent EC coupling,
a pore mutation (E1014K) known to entirely abolish the inward Ca2 current was introduced. 1S 671–690/720–765/
E1014K expressed Ca2 transients with Boltzmann parameters identical to those of the Ca2-conducting double deletion
construct. The data strongly suggest that skeletal-type EC coupling is not uniquely controlled by 1S 720–765. Other regions
of 1S or other DHPR subunits must therefore directly contribute to the activation of RyR1 during EC coupling.
INTRODUCTION
Skeletal muscle cells respond to membrane depolarization
with an elevation in cytosolic Ca2 that develops almost
instantaneously and is proportional to the duration of the
stimulus (Kim and Vergara, 1998). Two molecular com-
plexes responsible for coupling membrane excitation to
Ca2 elevation are the dihydropyridine receptor (DHPR) in
the transverse tubular membrane and the ryanodine receptor
type 1 (RyR1) in the sarcoplasmic reticulum (SR) mem-
brane (Block et al., 1988). Membrane depolarization is
thought to increase the SR Ca2 permeability by a confor-
mational change transmitted from the DHPR to the RyR1
via protein-protein interactions. The processes that couple
the movement of electrical charges in the DHPR to the
opening of the RyR1 channel have been under close scru-
tiny for many years (Rios and Pizarro, 1991; McPherson
and Campbell, 1993; Coronado et al., 1994; Meissner, 1994;
Sutko and Airey, 1996; Franzini-Armstrong and Protasi,
1997).
A critical structural determinant of excitation-contraction
(EC) coupling in skeletal muscle is the cytosolic loop be-
tween repeats II and III of the DHPR pore subunit 1S (Fig.
1 A). The II-III loop, under the influence of membrane
depolarization, has been suggested to trigger the release of
Ca2 from the SR (Tanabe et al., 1990; Garcia et al., 1994).
The II-III loop would thus function as a surrogate “gating
particle” which, after acquiring the correct conformation,
becomes a catalyst for the energetically unfavorable open-
ing of the RyR1 channel. Such a view represents a molec-
ular version of the mechanical plunger model suggested
earlier by Chandler et al., (1976). A prediction of this model
is that the II-III loop must contain molecular motifs essen-
tial for activation of the RyR1 channel. A search for differ-
ent regions of the II-III loop that affect RyR1 channel
activity was conducted using recombinant and synthetic
peptides (Lu et al., 1994; El Hayek et al., 1995; O’Reilly
and Ronjat, 1999; Dulhunty et al., 1999; Gurrola et al.,
1999; Casarotto et al., 2000). The strongest stimulation of
RyR1 channels in vitro was produced by a synthetic peptide
corresponding to 1S residues 671–690. A second peptide,
1S 724–760, had low stimulatory activity, but inhibited the
stimulatory activity of the 1S 671–690 peptide when both
synthetic peptides were presented to RyR1-containing skel-
etal SR vesicles (El Hayek et al., 1995). These biochemical
studies suggest that the region of the II-III loop encom-
passed by 1S 671–690 could be the structural element of
the II-III loop that triggers EC coupling in the muscle cell
(El Hayek et al., 1998).
A second region of the II-III loop critical for EC coupling
was identified in dysgenic myotubes by functional expres-
sion of chimeric cDNAs for DHPR pore subunits (Nakai et
al., 1998). This study showed that a chimera consisting of a
cardiac 1C subunit with 1S 720–765 replacing the homol-
ogous cardiac region expressed voltage-evoked Ca2 tran-
sients of near-normal amplitude. The narrower 1S 725–742
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region recovered a slightly lower than normal Ca2 tran-
sient. Furthermore, the Ca2 transients in each case per-
sisted in the presence of Ca2 channel blockers, indicating
recovery of skeletal-type EC coupling by the chimeras.
Thus the two screening strategies, namely peptide analysis
in vitro (El Hayek et al., 1995) and chimera analysis in situ
(Nakai et al., 1998), arrived at different conclusions regard-
ing the regions of the II-III loop essential for EC coupling
function. To gain more decisive information on the EC
coupling domains encoded by the II-III loop, we used a
deletion strategy. The data clearly show that 1S 720–765 is
essential, but 1S 671–690 can be deleted without a critical
loss of function. However, deletion of both regions, which
amounts to a loss of 50% of the II-III loop sequence, does
not entirely eliminate skeletal-type EC coupling. This result
suggests that regions outside the II-III loop could contribute
directly to the mechanism that activates RyR1 during EC
coupling. Part of these results were published in abstract
form (Ahern et al., 2001a).
MATERIALS AND METHODS
Primary cultures and cDNA transfection
Outbred Black Swiss mice (Charles River, MA) were used to generate
colonies of heterozygous dysgenic (1S
/mdg) and dyspedic (RyR1) mice
that were genotyped by PCR. RyR1 mice were a gift of Dr. H.
Takeshima; 1S null (1S
mdg/mdg) or RyR1 null (RyR1-/-) mice were gen-
erated by interbreeding of heterozygous parents. Primary cultures were
prepared from enzyme-digested hindlimbs of late-gestation (E18) 1S
mdg/
mdg or RyR1-/- fetuses as described (Beurg et al., 1997). cDNAs of interest
and a separate plasmid encoding the T-cell membrane antigen CD8 were
mixed at a 1:1 weight ratio and cotransfected with the polyamine LT-1
(Panvera, WI). CD8-transfected cells were recognized by incubation with
anti-CD8 antibody beads (Dynal, Norway). Determined by immunostain-
ing, 80% of the CD8-transfected dysgenic 1S null myotubes coex-
pressed the 1S cDNA of interest.
1S II-III loop deletions
All cDNA constructs were sequenced at least twice using BigDye tech-
nology (Perkin-Elmer, CA) at a campus facility. For epitope tagging and
expression in mammalian cells, the unmodified full-length rabbit 1S
cDNA encoding residues 1–1873 (Genebank M23919 nucleotide coordi-
nates nt 226 to nt 5847) was fused in frame to the first 11 amino acids of
the phage T7 gene 10 protein in the mammalian expression vector pSG5
(Stratagene, CA) using AgeI and NotI cloning sites. All constructs were
made using the T7-tagged 1S as template in PCR-based strategies. Gene-
bank M23919 nucleotide coordinates are used below to describe primers.
A silent HindIII site was introduced by PCR at nt 2228 in the full-length
1S template and cloned into the T7-1S pSG5 vector using AgeI and XhoI
sites. The HindIII-XhoI fragment (nt 2228 to nt 2878) encompassing the
II-III loop was subcloned into pCR 2.1 TOPO TA (Invitrogen, CA) and this
plasmid was further used for PCR reactions. PCR reactions consisted of 10
ng pCR 2.1 TOPO/HindIII-XhoI insert, 15 pmol of each primer, 0.5 mM
FIGURE 1 (A) Putative 1S II-III loop according to a sequence lineup of Perez-Reyes and Schneider (1994). Residues in bold indicate deleted regions.
(B) Confocal immunofluorescence of dysgenic myotubes expressing II-III loop deletions. Cells were transfected with CD8 cDNA plus the indicated
construct; 3 to 5 days after transfection, cells were incubated with CD8 antibody beads, fixed, and stained with anti-T7 primary/fluorescein-conjugated
secondary antibodies. Pixel intensity was converted to a 16-level inverted gray scale with high-intensity pixels in black. WT indicates full-length 1S used
as control. NF indicates a nontransfected myotube in the same focal plane of the transfected cell. Images are 50  80 m and on-focus beads are 4.5 m
in diameter.
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dNTPs, 1X cloned Pfu buffer (Stratagene) and 2.5U cloned Pfu DNA
polymerase (Stratagene). Amplification was carried out for 30 cycles at
95oC for 45 s, 60oC for 2 min, and 72oC for 2 min/kb of plasmid. The PCR
reaction was treated with 10U of DpnI (Stratagene) and recircularized with
T4 DNA ligase (Stratagene). Once amplified by PCR, the HindIII-XhoI
digest was ligated into the T7-1S pSG5 vector using the same restriction
sites. HPLC-purified primers (Operon, CA) were used in all PCR reactions
and were as follows: for 671–690 the antisense primer was complemen-
tary to nt 2202 to nt 2235 and the sense primer was nt 2296 to nt 2326; for
720–765 the antisense primer was complementary to nt 2340 to nt 2382
and the sense primer was nt 2521 to nt 2545; for 724–743 the antisense
primer was complementary to nt 2351 to nt 2394 and the sense primer was
nt 2455 to nt 2482. A phosphate was tagged to the 5-end of the sense
primer to recircularize the amplified TOPO vector. Double deletions
671–690/720–765 and 671–690/724–743 were produced sequen-
tially such that a pCR 2.1 TOPO vector with a HindIII-XhoI insert carrying
a deletion of nt 2236 to nt 2295 (1S residues 671–690) was used as
template for the second deletion using the same primers above.
671–690/720–765/E1014K
The XhoI-BglII fragment of the unmodified 1S template encompassing
residue E1014 (nt 2878 to nt 4712) was subcloned into a pCR 2.1 TOPO
TA vector. For the pore mutation, mismatches were introduced at nt 3265
(g3265a) for the E1014K substitution, and at nt 3297 (a3297c) and nt 3300
(c3300t) for the introduction of a unique ClaI site for identification of
E1014K clones. With these modifications, the sequence of the antisense
primer was 5CCTCCTCGTTGGAATCGATGGCCCTGTACAGCA-
GCTGGGGCCATCCCTTGAAGG 3 (italics are mismatched bases). The
sense primer was nt 3314 to nt 3349. The E1014K-substituted XhoI-BglII
fragment was ligated using XhoI and BglII sites in the T7-pSG5 1S
671–690/720–765 vector.
Whole-cell voltage-clamp
Cells were voltage-clamped 3 to 5 days after transfection. Transfected cells
revealed by CD8 beads were voltage-clamped with an Axopatch 200B
amplifier (Axon Instruments, CA) and a Digidata 1200 (Axon) pulse
generator and digitizer. Linear capacitance, leak currents, and effective
series resistance were compensated with the amplifier circuit. The charge
movement protocol included a long prepulse to inactivate Na channel
ionic and gating currents (Strube et al., 1996). Voltage was stepped from
a holding potential of 	80 mV to 	35 mV for 750 ms, then to 	50 mV
for 5 ms, then to the test potential for 50 ms, then to 	50 mV for 30 ms
and finally to the 	80 mV holding potential. Test potentials were applied
in decreasing order every 5 mV from 100 or 110 mV to 	75 mV. The
inter-test pulse period was 10 s. Nonlinear charge movement from a more
negative holding potential,	120 mV, resulted in Q-V curves with the same
maximum charge movement density. On-line subtraction of the linear
charge was done by a P/4 procedure. The P/4 pulses were delivered
immediately before the protocol from 	80 mV in the negative direction.
To verify that the P/4 pulses adequately subtracted the linear component of
the charging current, we investigated the voltage-dependence of the cell
membrane capacity in the range of 	80 to 	120 mV. In this range, the
membrane capacity varied linearly with voltage, within a 0.5% error, in all
cells investigated (20 cells). Controls indicated that nontransfected dys-
genic myotubes (see Table 1) had minimal charge movement and did not
generate detectable Ca2 transients. An overwhelming majority of these
cells (45 of 47) did not express the low-density dysgenic Ca2 current
described elsewhere in dysgenic mice of a different genetic background
(Strube et al., 1998). The voltage dependence of charge movements (Q),
peak intracellular Ca2 (F/F), and Ca2 conductance (G), was fitted
according to a Boltzmann distribution (Eq. 1) A 
 Amax/(1  exp(	(V 	
V1/2)/k)). Amax is Qmax, F/Fmax, or Gmax; V1/2 is the potential at which A

Amax/2; and k is the slope factor.
Solutions
The external solution in all cases was (in mM): 130 TEA methanesulfonate,
10 CaCl2, 1 MgCl2, 10 HEPES titrated with TEA(OH) to pH 7.4. For Ca
2
transients and Ca2 currents, the pipette solution was (in mM): 140 cesium
aspartate, 5 MgCl2, 0.1 EGTA (Ca
2 transients) or 5 mM EGTA (Ca2
currents and specified Ca2 transients), and 10 MOPS-CsOH pH 7.2. For
TABLE 1 Ca2 conductance, charge movement, and Ca2 transients of 1S deletion mutants
Q-V F/F-V G-V
Qmax
(fC/pF) V1/2 (mV) k (mV) F/Fmax V1/2 (mV) k (mV)
Gmax
(pS/pF) V1/2 (mV) k (mV)
1S null 0.8  0.2* 	1.7  3.7* 11.9  2.2* — — — — — —
(12) (24) (45)
RyR1 null 3.9  0.5* 17.4  4.5 15.9  1.0* — — — 31.3  6.1* 11.6  3.0 6.3  0.5
(9) (9)
671–690 5.4  0.5 15.5  1.9 20.3  2.2 3.1  0.4 10.9  1.6 11.2  1.0 105  9.2 30.5  3.5 4.3  1.1
(6) (8) (6)
720–765 5.5  0.8 21.0  5.6 24.7  1.7 — — — — — —
(6) (7) (13)
724–743 5.5  0.5 14.0  2.3 17.9  0.9 — — — — — —
(4) (8) (8)
671–690/ 5.3  0.8 21.5  5.5 21.3  2.0 0.5  0.1* 9.5  4.5 9.5  0.6 63.8  7.1* 31.5  1.6 6.5  0.5
720–765 (5) (13) (5)
671–690/ 6.2  1.3 15.3  5.4 18.1  2.6 — — — 79.2  6.3* 28.8  2.7 5.8  0.6
724–743 (4) (9) (6)
WT 6.3  0.2 16.7  3.5 19.6  1.4 2.9  0.4 11.0  1.9 8.4  1.0 109.5  8.3 25.5  2.1 4.9  0.7
(6) (11) (7)
Entries correspond to mean SEM of Boltzmann parameters fitted to each cell. The number of cells is in parentheses. Conflocal fluo-4 fluorescence change
(F/F  0.2) or L-type Ca2 current (20 pA/cell) were not detectable in the indicated number of cells.
*Data compared to control (WT) with t-test significance p 0.05. One-way ANOVA of Qmax, Q1/2, Qk, F/F1/2, F/Fk, G1/2, and Gk of II–III loop deletion
constructs and WT had significance p 0.18. Excluded from the conductance averages are two cells expressing 671–690/720–765 that had undetectable
L-type Ca2 current, but large charge movements (Qmax 
 4.9 and 4.6 fC/pF).
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charge movements, the internal solution was (in mM): 120 NMG (N-
methyl glucamine)-glutamate, 10 HEPES-NMG, 10 EGTA-NMG, pH 7.3
(Ahern et al., 2001b). For charge movements the external solution was
supplemented with 0.5 mM CdCl2 and 0.5 mM LaCl3 to block the Ca
2
current and 0.05 mM TTX to block residual Na current.
Confocal fluorescence microscopy
Confocal line-scan measurements were performed as described (Beurg et
al., 1999a, b; Conklin et al., 2000). Cells were loaded with 4 mM fluo-4
AM (Molecular Probes, OR) for 30 min at room temperature. When
indicated, cells were dye-loaded through the patch pipette with internal
solution supplemented with 1 mM fluo-4 (free acid). Dye fluorescence was
imaged in an inverted Olympus microscope with a 20 objective (N.A.
0.4) and a Fluoview confocal attachment (Olympus, NY). Excitation light
was provided by a 5 mW Argon laser attenuated to 6% with neutral density
filters. In line-scan mode the line had a dimension of 512 pixels (0.3–0.4
m/pixel) and the acquisition period of a single 512-pixel line was 2.05
ms.
Immunostaining
Transfected cells were kept in culture for 3 to 5 additional days and
afterward fixed and processed for immunofluorescence (Beurg et al.,
1999b; Ahern et al., 2001b). Controls shown elsewhere indicated that
dysgenic myotubes do not express the mdg gene product, a truncated 1S,
at levels detectable by our immunostaining technique (Strube et al., 1998);
1S was identified with a mouse monoclonal antibody against a T7 epitope
fused to the N-terminus of the 1S construct. The anti-T7 antibody (No-
vagen, Madison, WI) was used at a dilution of 1:1000. The secondary
antibody was a fluorescein-conjugated goat anti-mouse IgG (Boehringer
Mannheim, Indianapolis, IN) used at a dilution of 1:1000. Confocal images
of immunofluorescence had a dimension of 1024  1024 pixels (0.35
m/pixel) and were obtained with a 40 oil-immersion objective (N.A.
1.3). Images were Kalman-averaged three times and the pixel intensity
displayed as 16 levels of gray in reverse. All images were acquired using
minimal laser power and predetermined PMT settings to avoid pixel
saturation and for accuracy in the comparison of images.
RESULTS
All constructs carried an 11-residue T7 tag at the N-termi-
nus, which is useful for determining relative protein expres-
sion levels. Constructs were transiently expressed in dys-
genic myotubes using the pSG5 mammalian expression
vector and were identified by the deleted residues. A T7-
tagged full-length 1S expressed in dysgenic myotubes was
used as control and was identified as WT. Fig. 1 B shows
confocal images in reverse contrast of dysgenic myotubes
fixed and immunostained with anti-T7 antibody and a flu-
orescein-conjugated secondary antibody. A CD8 cDNA was
used as a transfection marker, and beads coated with an
anti-CD8 antibody against an external epitope were used to
identify transfected cells. In all the images, in-focus beads
are 4.5 m in diameter. For comparison, a nontransfected
cell (NT) in the same confocal plane as the transfected cell
is indicated next to the myotube expressing 671–690/
724–743. The overall T7 staining pattern varied between
diffuse and punctate, with no correlation between the stain-
ing pattern and the expressed construct. We found abundant
expression of each of the tested constructs in the periphery
of the nuclei, which in the images appear as ellipsoids
devoid of stain. Three nuclei in a row are evident in the
myotube expressing 671–690. The perinuclear staining
presumably corresponds to immature 1S subunits traffick-
ing through the endoreticular membrane network. We also
found abundant staining in the periphery of the cell in areas
clearly separated from the endoreticular network. This is
most clear in the myotube expressing 720–765. The pe-
ripheral staining is entirely consistent with the known loca-
tion of functional DHPRs in cultured myotubes. At these
peripheral locations, couplings are established between the
surface and SR membranes (Takekura et al., 1994).
To determine the density of voltage-sensors expressed by
each construct we used a gating current protocol. The inset
in each of the six panels of Fig. 2 shows intramembrane
currents produced by the movement of charges in the ex-
pressed construct in response to a voltage step to 90 mV.
The traces show transient outward current at the start of a
50-ms voltage step as the charges move in the outward
direction (ON charge) followed by inward current at the end
of the voltage step as charges return to the original position
(OFF charge). We found a good correspondence between
the magnitude of the ON and OFF components, as would be
expected if charge movements were due to reversible dis-
placements of intramembrane charges. The graphs in Fig. 2
show charge versus voltage relationships for six of the
seven tested constructs obtained by integration of the OFF
component, which usually was less contaminated by ionic
current than the ON component. The voltage dependence of
the mean charge was fit in each case to a Boltzmann
equation (Eq. 1), which is indicated by the sigmoidal line.
The background charge present in nontransfected cells is
shown by the filled squares under the control curve of cells
expressing full-length 1S (WT, top left panel). In all cases,
the near-maximum charge density measured at large posi-
tive potentials was 5 to 8-fold above the background den-
sity. At 100 mV, the experimental charge density was
90% of the fitted Qmax, indicating that the chosen range of
test pulses was adequate to detect the bulk of the nonlinear
charge movements. This can be seen by comparing
Qexp(100) in Fig. 2 and Qmax in Table 1. A cell by cell
analysis of the averages shown in Fig. 2 further confirmed
that the fitted Boltzmann parameters (Qmax, V1/2, k) were not
significantly different from control (see Table 1). The sim-
ilarity in Qmax indicated that the II-III loop deletions did not
interfere with the voltage-sensing properties of the DHPR or
the trafficking of the DHPR complex to the cell surface.
Likewise, the similarity in midpoint potential (V1/2) and
steepness (k factor) suggested that the deletions were of
minimal consequence for the electrical characteristics of the
DHPR voltage sensor.
Depolarization-evoked Ca2 transients are shown in Fig.
3. We measured the confocal fluorescence of fluo-4 in
line-scan acquisition mode. A representative line-scan in
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response to a 50-ms depolarization to 90 mV from a
holding potential of 	40 mV is shown in each panel. A
second line-scan in some panels shows a Ca2 transient
activated by 10 mM caffeine in a myotube expressing the
same construct. All line-scan images have a duration (x
axis) of 2.05 s and a variable cell dimension (y axis)
indicated in the figure legend. Line-scans were integrated
across the y axis to obtain the time course of the average
fluorescence change. The highest fluorescence intensity
during 1.9 s following the depolarization, the peak fluores-
cence, is shown in each panel as a function of voltage. For
WT, 671–690, and 671–690/720–765, the mean peak
fluorescence was fit to a Boltzmann equation indicated by
the sigmoidal line. As shown by the top left and center
panels of Fig. 3, 671–690 expressed a Ca2 transient
versus voltage relationship strikingly similar to that ex-
pressed by the control construct. Hence, the 671–690 region
could not possibly have an essential role in the activation of
Ca2 transients in this expression system. This conclusion
was further supported by a cell-by-cell analysis of the
Boltzmann parameters (Table 1) compared to control (t-test
significance p 
 0.68, 0.98, 0.17 for F/Fmax, V1/2, and k,
respectively). In contrast, 720–765 failed to evoke Ca2
transients entirely (Fig. 3, top right). Consequently, the
latter region of the II-III loop and not the 671–690 region
was critical for triggering Ca2 transients. The limit of
fluorescence detection, based on microscope settings and
the average resting fluo-4 fluorescence, was 0.1 F/F
units; that is, we could detect an 10% change above the
cell resting fluorescence. Using a pseudo-ratiometric equa-
tion for estimating the cytosolic free Ca2 and assuming a
resting free Ca2 of 100 nM (Conklin et al., 1999), the
nominal limit of resolution of free Ca2 change was 200
nM; thus changes in free Ca2 concentration under this
limit could have taken place and would have escaped de-
tection. Because 720–765 removes more than twice as
many residues as 671–690, we tested the narrower 1S
724–743 region, which also confers skeletal EC function to
a cardiac 1C subunit (Nakai et al., 1998). We found that
724–743, like the longer deletion of the same region,
FIGURE 2 Intramembrane charge movements expressed by II-III loop deletions. The insets show nonlinear intramembrane current in dysgenic myotubes
expressing the indicated construct. The test potential was to90 mV with pre-test and post-test pulses indicated in Materials and Methods. The capacitance
of each cell (in pF) is from left to right; top: 388, 386, 166; bottom: 266, 347, 185. Scale bars are 0.5 nA and 25 ms. The graphs show the voltage dependence
of the population average intramembrane charge fitted to a Boltzmann equation. Parameters of each fit are from left to right; top: (Qmax in fC/pF, V1/2 in
mV, k in mV): 6.6, 12.1, 22; 5.9, 18, 23.2; 5.4, 21.8, 25.1; bottom: 5.5, 13. 3:17.8; 4.9, 20.1, 23.3; 5.9, 13.6, 18. Parameters of the fit of non-transfected
cells (squares) are: 0.8, 11.2, 10.5. The experimental charge (mean SEM) at Vtest
100 mV was (in fC/pF) 6.4 0.6 for WT; 5.5 0.6 for 671–690;
5.2  0.8 for 720–765; 5.5  0.6 for 724–743; 4.8  0.6 for 671–690/720–765; and 6.1  1.1 for 671–690/724–743.
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abolished Ca2 transients entirely (Fig. 3, bottom left). Loss
of Ca2 transients could be due to a loss of Ca2 storage
capacity of the transfected cell, so to rule out this possibility
cells expressing 720–765 or 724–743 were perfused
with external solution supplemented with 10 mM caffeine.
The insets in Fig. 3 show that caffeine evoked robust Ca2
transients and thus the Ca2 storage capacity of transfected
cells was not adversely modified. The absence of Ca2
transients in the presence of normal charge movements
suggested that 724–743 and 720–765 expressed a
DHPR in which the voltage sensor was truly uncoupled
from SR Ca2 release.
Residues 671–690 and 720–765 are the only two regions
of the II-III loop that have been reported to screen positively
for EC coupling-related functions, albeit by different tech-
niques. We thus investigated whether voltage-evoked Ca2
transients were expressed when both regions were removed
from the II-III loop. Surprisingly, the bottom center panel of
Fig. 3 shows that 671–690/720–765 expressed Ca2
transients that increased with depolarization and saturated at
a maximum amplitude (F/Fmax) 20% of control. This
result was highly consistent and was observed in 13 of 13
myotubes from three batches of cultured cells. Analysis of
the voltage-dependence of the Ca2 transient showed that
neither the midpoint potential nor the steepness of the
fluorescence versus voltage relationship was affected by
this double deletion (Table 1). These results provide a clear
indication that the skeletal DHPR has a latent EC coupling
activity that is unmasked by simultaneous removal of resi-
dues 671–690 and 720–765. In molecular terms, the 720–
765 region could be a conformation-sensitive region of the
II-III loop stabilized by strong residue-residue interactions
with other regions of the II-III loop. Thus, the loss of EC
coupling produced by removal of residues 720–765 could
FIGURE 3 Ca2 transients expressed by II-III loop deletions. The insets show confocal line-scan images of fluo-4 fluorescence in response to a 50-ms
depolarization to 90 mV from a holding potential of 	40 mV. Pseudo-colors cover four F/units (blue  0.2 to red  4). The line-scan duration (x axis)
was 2.05 s and the cell dimension (y axis) was (in m) from left to right; top: 16.7, 48.8, 20.2; bottom: 25.7, 29.9, 86.9. In some panels a second line-scan
shows a Ca2 transient after perfusion with external solution containing 10 mM caffeine. The graphs show the population average voltage dependence of
the Ca2 transient measured in resting fluorescence units fitted to a Boltzmann equation. Parameters of each fit are from left to right; top: (F/Fmax, V1/2
in mV, k in mV): 2.7, 12.4, 7.9; 2.8, 12.2, 9.5; none; bottom: none; 0.38, 13.4, 14; none.
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be the result of a conformation change that is partially
reverted by a second conformational change in the II-III
loop produced by removal of residues 671–690. To further
test whether the latent EC coupling activity could have
originated from additional regions of the II-III loop, we
deleted all the sequence between the two deletions, namely,
residues 671–765. Unfortunately, 671–765 failed to ex-
press charge movements, hence these data were not in-
cluded in the present analysis. We also tested EC coupling
recovery by 671–690/724–743 (Fig. 3, bottom right).
The results with the latter construct were far less consistent,
and small Ca2 transients (F/Fmax0.2) were only ob-
served in 2 of 11 cells from three batches of cultured cells.
The reasons for this inconsistency are not clear, especially
since this double deletion removes fewer residues from the
II-III loop than 671–690/720–765.
We further investigated whether the Ca2 current ex-
pressed by 671–690/720–765 contributed to the trigger-
ing of the Ca2 transient. Ca2-entry dependent EC cou-
pling is normally not present in skeletal myotubes, but can
be induced by expression of 1C in dysgenic myotubes or
modified DHPR  subunits in  null myotubes (Garcia et
al., 1994; Sheridan et al., 2001). In the present case, such a
mechanism could have been induced by an aberrant confor-
mation of the 1S protein carrying the two internal dele-
tions. A straightforward pharmacological intervention con-
sists of comparing Ca2 transients in the presence and
absence of inorganic Ca2 channel blockers. However,
these compounds are known to partially, yet significantly,
depress voltage-evoked Ca2 transients in skeletal myo-
tubes (see Fig. 3A of Wilkens et al., 2000). To avoid this
complication, we blocked the Ca2 current by replacing a
conserved pore glutamate by lysine at position 1014 in
repeat III of 1S. The E1014K substitution in a full-length
1S was previously shown to abolish the inward Ca
2
current entirely, yet the magnitudes of the expressed Ca2
transients were unaltered (Dirksen and Beam, 1999). In Fig.
4 A we compared whole-cell currents expressed by 671–
690/720–765 and 671–690/720–765/E1014K in stan-
dard external solution containing 10 mM Ca2 at the indi-
cated potentials from a holding potential of 	40 mV. In
agreement with the previous results (Dirksen and Beam,
1999) inward currents during the pulse were entirely abol-
ished by the E1014K substitution. To determine whether
inward tail currents were present, the residual cell capaci-
tance was subtracted with a	P/4 protocol. Selected voltage
steps that activated large currents during the pulse, namely
30 mV for the Ca2-conducting construct and70 for the
pore mutant, were preceded by 	P/4 pulses of the same
duration and delivered from the same holding potential. Fig.
4 B shows difference currents after 	P/4 subtraction at the
two potentials indicated above and at 	30 mV that did not
activate ionic currents. The results indicated that inward tail
currents were not present in the 671–690/720–765/
E1014K construct. The voltage dependence of the pulse
current is shown in Fig. 4 C. Starting at 20 mV, the
E1014K substitution unmasked a large outwardly rectifying
current which in native Ca2 channels is observed at much
higher potentials (Hess et al., 1986). More importantly,
inward current was not present in the E1014K construct
over the entire range of voltages used to activate the Ca2
transient. In Fig. 5 A we compare Ca2 transients and
whole-cell currents expressed in the same cell by 671–
690/720–765 and 671–690/720–765/E1014K. The
time course and amplitude of the Ca2 transients were
remarkably similar despite the presence of a measurable
Ca2 current in the Ca2-conducting construct and the
absence of inward currents in the E1014K construct at all
potentials. Furthermore, the voltage-dependence of the
Ca2 transient collected in several cells (Fig. 5 B) were
indistinguishable (t-test significance p 
 0.13, 0.9, 0.38 for
F/Fmax, V1/2, and k, respectively). Thus, the EC coupling
recovered by 671–690/720–765 was strictly a Ca2-
entry independent skeletal-type EC coupling.
The kinetics of SR Ca2 release can be inferred from the
time course of the Ca2 transient measured in the presence
of a Ca2 buffer that eliminates fluorescence due to Ca2
accumulation in the cytosol. In a Ca2-buffered internal
solution, the rate of change of cytosolic Ca2 approximates
the net difference between the rate of SR Ca2 release and
the rate of cytosolic Ca2 removal (Melzer et al., 1984).
Furthermore, because the SR Ca2 release rate is much
faster than the Ca2 removal rate, d(F/F)dt immediately
after the depolarization is dominated by the SR Ca2 release
rate (Melzer et al., 1984). Fig. 6 A shows Ca2 transients
obtained by integration of confocal line-scans in myotubes
internally dialyzed with internal solution supplemented with
5 mM EGTA and 1 mM fluo-4 free acid present in the patch
pipette. Due to the sharp diminution in the amplitude of the
fluorescence signal produced by EGTA, we could only
perform these experiments in cells transfected with the
control construct and 671–690, which expressed compar-
atively large Ca2 transients. In response to a 50-ms depo-
larization there was a rapid increase in cytosolic Ca2
followed by an equally fast decay upon termination of the
depolarization. The fast decay was followed by a much
slower component that was completed in the time scale of
seconds. The time course of the fast component is consistent
with the rate of termination of SR Ca2 release, which for
short depolarizations has a time constant of tens of milli-
seconds in adult frog fibers (Simon et al., 1989). The slow
component is consistent with Ca2 removal stimulated by
the Ca2 pump, although this has not been determined. The
rate of change of fluorescence during the depolarization,
d(F/F)/dt, is shown in Fig. 6 B for a pulse to90 mV. For
both constructs there was a sharp increase in the rate of
change of fluorescence followed by an equally fast decline
while the pulse was at 90 mV. This result is entirely
consistent with determinations in adult rat skeletal muscle
and suggests the presence of fast rates of activation and
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inactivation of SR Ca2 release (Shirokova et al., 1996;
Szentesi et al., 1997). Fig. 6 C shows the peak rate of
fluorescence change during the upstroke of the depolariza-
tion for the control construct and 671–690 at two poten-
tials. In both cases the rate of cytosolic Ca2 increase was
comparatively faster for 671–690 (p  0.05). However,
since the rate of fluorescence change and the confocal scan
rate (2.05 ms per scan) were of the same magnitude, the
results must be interpreted with caution. At the very least,
these results indicate that the Ca2 release rate expressed by
671–690 is not kinetically impaired. A submillisecond-
scanning confocal microscope would be required to fully
resolve the Ca2 release rate expressed by this construct.
The voltage dependence of the Ca2 conductance ex-
pressed by the II-III loop deletion constructs is shown in
Fig. 7. In each panel the sigmoidal line shows a Boltzmann
fit of the mean conductance and the inset shows whole-cell
Ca2 current in response to a voltage step to 30 mV from
a holding potential of 	40 mV. The endogenous dysgenic
Ca2 current (not shown) was detected in only 2 of 47
nontransfected myotubes analyzed at a resolution of 20
pA/cell. This is a Ca2 current of low-density and fast
activation kinetics previously described in dysgenic myo-
tubes (Adams and Beam, 1990) and, in our hands, is far
more frequent in mice of a different genetic background
(Strube et al., 1998). The maximum Ca2 conductance,
Gmax, of the control construct was 110 pS/pF with a
half-activation potential of 25 mV (Fig. 7, top left). The
mean Gmax expressed by 671–690 (top center) was simi-
lar, although the half-activation potential was slightly more
FIGURE 4 Current-voltage relationships expressed by 671–690/720–765 with an additional E1014K pore mutation. (A) Whole-cell currents in
standard Ca2-recording external solution are shown for a dysgenic myotube expressing 671–690/720–765 (C 
 347 pF) and a myotube expressing
671–690/720–765/E1014K (C 
 324 pF). Voltage steps were for 500 ms from a holding potential of 	40 mV. Calibration bars are 500 pA and 100
ms. (B) The indicated voltage steps were preceded by 4 -P/4 pulses of the same duration from	40 mV. The P/4 subtracted traces are shown. (C) Population
average current vs. voltage curves for five cells expressing each construct.
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positive. However, a cell-by-cell analysis (Table 1) did not
reveal significant differences in any of the fitted Boltzmann
parameters compared to control (t-test significance p 

0.72, 0.23, and 0.59 for Gmax, V1/2, and k, respectively).
Ca2 current was undetectable (20 pA/cell) in the major-
ity of myotubes expressing 720–765 or 724–743 (13 of
16 cells from six cultures and 8 of 11 cells from three
cultures, respectively). However, in a few instances these
two constructs expressed a measurable Ca2 current of a
magnitude 4-fold lower than WT control (not shown).
Because all cells analyzed expressed charge movements in
a consistent manner (Table 1), the inability of these two
constructs to express Ca2 current was unrelated to the lack
of targeting of DHPRs to the cell membrane. In contrast, the
double deletion constructs expressed, in the majority of
tested cells, a high-density Ca2 current of approximately
half the control density, 60–70 pS/pF (Fig. 7, bottom left
and right). Ca2 current expression by 671–690/720–
765 and 671–690/724–743 was observed in 5 of 7 cells
from four cultures and 6 of 6 cells from three cultures,
respectively. Two cells expressing the former construct
failed to express Ca2 current but expressed large charge
movements, which are indicated in the figure legend. Ca2
current expression by 671–690/724–743 was observed
consistently and this result was deemed highly significant
since, at the same time, this construct consistently failed to
trigger Ca2 transients. Thus, there is a clear molecular
distinction between the structural determinants of the Ca2
current and those of EC coupling. In summary, the severe
decrease in Ca2 conductance produced by 724–743 and
720–765 agrees with previous observations showing that
this region of the II-III loop controls expression of the
L-type Ca2 current and is critical for retrograde signaling
from RyR1 to the DHPR (Grabner et al., 1999). However,
the observation that the preponderance of cells transfected
with 671–690/720–765 and 671–690/724–743 ex-
pressed a high-density Ca2 current is difficult to explain
within the boundaries of the present understanding of ret-
rograde signaling (see Discussion).
A physical uncoupling of the DHPR and RyR1 occurs in
RyR1 null myotubes, and this is manifested in the kinetics
of activation of the L-type Ca2 current, which is signifi-
cantly faster in RyR1 null than in normal myotubes (Avila
and Dirksen, 2000). Because 671–690/724–743 was
FIGURE 5 Skeletal-type EC coupling expressed by 671–690/720–765/E1014K. (A) Confocal Ca2 transients at the indicated potentials are shown
for a dysgenic myotube expressing 671–690/720–765 (C 
 265 pF) and a myotube expressing 671–690/720–765/E1014K (C 
 284 pF). The time
course of the transient was obtained by integration of line-scan images of fluo-4 fluorescence for 2.05 s. The 50-ms depolarization used to stimulate the
Ca2 transient is indicated by the square pulse and the whole-cell current during the depolarization is shown expanded next to the trace of florescence.
Current calibration bars (25 ms, 1 nA) and fluorescence calibration bars (500 ms, 0.25 F/F) are the same for both cells. (B) Population average Ca2
transient versus voltage curves for five cells expressing each construct with Boltzmann parameters (F/Fmax, V1/2 in mV, k in mV) left: 0.38, 13.4, 14; right:
0.34, 20.3, 11.5.
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unable to couple voltage-sensing to SR Ca2 release but
671–690/720–765 produced a consistent EC coupling,
we compared the kinetics of activation of the Ca2 currents
expressed by both constructs. Such an analysis could pro-
vide an indication of whether 671–690/724–743 induces
a physical separation of the DHPR and RyR1. Fig. 8 A
shows scaled Ca2 currents in response to a depolarization
to 40 mV from a holding potential of 	40 mV. In agree-
ment with the previous study (Avila and Dirksen, 2000), we
found that Ca2 current activation was composed of a fast
component followed by a much slower component during
prolonged depolarization. In the current records (gray trac-
es), the slow component is noticeable at times longer than
50 ms. The visual impression was confirmed by chi-square
tests performed on monoexponential (2 
 84 and 3.8 for
RyR1 null and control, respectively) and biexponential (2

 0.21 and 1.88, respectively) fits and the latter are shown
in Fig. 8 A by the dark lines. As shown by the histograms in
Fig. 8 B, the fast and slow components of activation were
comparatively faster in RyR1 null than in control myotubes,
which is also in agreement with the previous study. The
kinetics of activation of the Ca2 current expressed by
671–690/720–765, 671–690/724–743, and 671–
690 were not significantly different from control but signif-
icantly slower than the Ca2 current of RyR1 null myo-
tubes. Several statistical analyses of these data and the
relative amplitude of the two components of the exponential
fits are indicated in the figure legend. The kinetics of
activation of the L-type Ca2 current was previously sug-
gested to vary with the level of expression of 1S in myo-
tubes (Adams et al., 1996). In Fig. 8, C and D, we plotted
the fitted activation time constant as a function of the Ca2
current density for each cell. These data show that within
the range of Ca2 current density achieved in the present
study, namely 1–5 pA/pF, we did not find such a correlation
for any of the constructs, either separately or pooled (R2 

0.21 and 0.18 for plots in Fig. 8, C and D, respectively).
Hence, the similar activation kinetics of 671–690/720–
765, 671–690/724–743, 671–690, and WT observed
here are more likely to reflect inherent properties of the
DHPR-RyR1 interaction rather than the level of maturity of
the myotube. In summary, the kinetics of activation of the
expressed L-type Ca2 current strongly supports the view
that the EC uncoupled phenotype of 671–690/724–743
or the partially coupled phenotype of 671–690/720–765
may not involve a physical separation of the DHPR and RyR1.
FIGURE 6 Rate of Ca2 release expressed by 671–690. (A) Confocal Ca2 transients at the indicated potentials are shown for a dysgenic myotube
expressing full-length 1S (C 
 286 pF) and a myotube expressing 671–690 (C 
 325 pF). The time course of the transient was obtained by integration
of line-scan images of fluo-4 fluorescence. The 50-ms depolarization used to stimulate the Ca2 transient is indicated by the square pulse. The internal
(pipette) solution contained 5 mM EGTA and 1 mM fluo-4 free acid. Fluorescence calibration bar is 0.5 F/F. (B) Representative time derivatives of
confocal Ca2 fluorescence, in F/F units, for a depolarization to 90 mV. (C) The peak rate of fluorescence change at the onset of the depolarization
is shown at two potentials for the indicated number of cells. Data sets with t-test statistical significance p  0.05 are shown by asterisks.
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DISCUSSION
The main observations of the present work are as follows: 1)
removal of 1S II-III loop residues 671–690 does not elim-
inate the EC coupling and Ca2 channel functions of the
DHPR; 2) removal of 1S residues 720–765 or residues
724–743 eliminates EC coupling entirely and most of the
Ca2 current; 3) removal of 1S residues 720–765 and
residues 671–690 partially but not entirely eliminates skel-
etal-type EC coupling and Ca2 current; and 4) removal of
1S residues 724–743 and residues 671–690 eliminates EC
coupling entirely, but Ca2 current only partially. Observa-
tions (1) and (2) allow us to conclude unambiguously that
1S 720–765 is an EC coupling-sensitive region of the II-III
loop, whereas 1S 671–690 is dispensable. Also, (3) sug-
gests that regions other than 1S 671–690 and 1S 720–765
are directly engaged in voltage-dependent activation of
RyR1. Finally, (4) demonstrates that the Ca2 channel and
EC coupling functions of the DHPR have different molec-
ular underpinnings.
Previously, functional expression studies in dysgenic cells
were unable to demonstrate an influence of 1S 671–790 in the
EC coupling characteristics of myotubes when this region of
1S was replaced by the homologous region of mammalian
cardiac 1C (Nakai et al., 1998) or replaced by a nonhomolo-
gous II-III loop of invertebrate origin (Wilkens et al., 2001).
Furthermore, scrambling of the RKRRK binding motif of 1S
671–790 (Proenza et al., 2000a) or complete deletion of the
region (Ahern et al., 2001b) failed to significantly alter the
skeletal EC coupling phenotype. However, in the present work,
the removal of 1S 671–790 was not entirely without conse-
quence. Deletion of this region had an unforeseen positive
effect of the kinetics of SR Ca2 release and was critical for
unmasking the new component of EC coupling observed in the
absence of 1S 720–765; hence 1S 671–790 is neither func-
tionally or structurally inert. The two experimental observa-
tions mentioned above are consistent with the view that the
671–790 region participates in negative control either slowing
the rate of SR Ca2 release or altogether blocking SR Ca2
release initiated by signals elsewhere in the DHPR.We realize,
however, that a proposed inhibitory function of the 671–690
region is in sharp contrast with the stimulatory effect of the
671–690 peptide on RyR1 channels reported in several studies
FIGURE 7 Ca2 conductance expressed by II-III loop deletions. The insets shows whole-cell Ca2 currents in dysgenic myotubes expressing the
indicated construct. 720–765 and 724–743 did not express Ca2 currents consistently and are not shown. The depolarizing potential was 30 mV for
500 ms from a holding potential of 	40 mV. The capacitance of each cell (in pF) is from left to right; top: 247, 258; bottom: 314, 255. Scale bars are 1
nA and 250 ms. The graphs show the voltage dependence of the population average Ca2 conductance fitted to a Boltzmann equation. Parameters of the
fit (Gmax in pS/pF, V1/2 in mV, k in mV) are from left to right; top: 107.4, 28.4, 6.6; 108.1, 32.9, 7.1; bottom: 60.7, 31.3, 6.7; 77.1, 23.8, 6.2.
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(cited in the Introduction). It is important to keep in mind that
RyR1 channels respond to many different kinds of ligands (see
Table 2 of Coronado et al., 1994), including charged ligands
such as polylysine (El-Hayek and Ikemoto, 1998). We would
thus speculate that the lysine/arginine RKRRK motif of the
671–690 peptide might have contributed to overrepresent the
stimulatory activity of the 1S 671–690 peptide over and
above that of other II-III loop peptides tested (Saiki et al., 1999;
Stange et al., 2001).
The critical participation of 1S 720–765 in EC coupling,
the region previously identified by functional screening of
1C/1S chimeras, was reaffirmed by the present results.
However, the data also showed that a signal capable of
triggering skeletal-type EC coupling was generated else-
where when 1S 720–765 and 1S 671–690 were absent. It
could be argued that the double 1S 671–690/720–765
deletion produced artifactual interactions with RyR1 and
that these interactions, normally not present between 1S
and RyR1, would be responsible for the recovered EC
coupling. This possibility is considered highly unlikely due
to three fundamental reasons. First, the Boltzmann param-
eters of charge movement expressed by the double deletion
construct and those expressed by the control construct are
statistically undistinguishable (t-test significance p  0.12).
Hence the trigger signal itself was not altered. Second,
except for the maximum amplitude of the Ca2 transient,
the midpoint potential and the steepness factor k of the Ca2
transient versus voltage curve were identical to controls.
Therefore, the characteristics of the outgoing signal that
activates the Ca2 transient were only partially modified.
Finally, the kinetics of the expressed Ca2 current was
identical to that expressed by the control construct. Conse-
quently, retrograde signaling from the RyR1 to the DHPR
was not modified. None of these results is consistent with
the presence of artifactual interactions. Of these results, the
slow biphasic Ca2 current recovered by 671–690/720–
765, with a kinetics of activation similar to the control Ca2
current (Fig. 8), was deemed especially significant. It has
FIGURE 8 Kinetics of activation of the Ca2 current expressed by II-III loop deletions. (A) Normalized whole-cell Ca2 current (gray traces) during
a depolarization to 40 mV from a holding potential of 	40 mV. The pulse duration was 500 ms and only the initial 120 ms are shown. The first 16 ms
of the trace were omitted. The line is a biexponential fit of the pulse current 16 ms after the onset of the pulse with fast and slow time constants, in ms,
from left to right: 2.7, 16.1; 15.7, 165; 31.9, 165; 13.9, 135; 8.7, 159. The pre-exponential factors of the fast and slow components were, respectively, from
left to right: 0.26, 0.74; 0.62, 0.38; 0.51, 0.49; 0.46, 0.54; 0.5, 0.5. (B) Averages of the fitted fast and slow activation time constants (mean  SE) for the
indicated number of cells. All data (fast versus slow time constants) had t-test significance p  0.05. Activation time constants of RyR1 null and WT (fast
versus fast and slow versus slow time constants) were significantly different (t-test significance p  0.05). Activation time constants of WT control and
II-III loop deletion constructs (fast versus fast and slow versus slow) were not significantly different (ANOVA significance p 0.23). The average (mean
SE) pre-exponential factors of the fitted fast and slow components for the same cells were 0.29  0.06 and 0.71  0.14 for RyR1 null; 0.34  0.08 and
0.66  0.16 for WT; 0.35  0.1 and 0.65  0.18 for 671–690; 0.46  0.12 and 0.54  0.14 for 671–690/720–765; 0.45  0.13 and 0.55  0.16
for 671–690/724–743. (C, D) Time constants of activation are plotted as a function of the maximum Ca2 current density of each cell. Black circles
(WT), open circles (671–690), black diamonds (671–690/720–765), open diamonds (671–690/724–743).
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been argued that 1S 720–765 modulates expression of the
Ca2 current by retrograde signaling from the RyR1 to the
DHPR. The recovery of more than half of the control Ca2
conductance by 671–690/720–765 and by 671–690/
724–743 demonstrates that this region of the II-II loop is
unlikely to harbor a unique signal controlling Ca2 current
expression. Instead of a signaling domain, the 720–765
region could be a conformation-sensitive “permissive” re-
gion controlling protein folding. Disruption of proper pro-
tein folding by deletion of residues in this region could
impair EC coupling signals generated elsewhere in the
DHPR. Alternatively, 1S 720–765 may be one of several
regions involved in bidirectional signaling between the
DHPR and RyR1. The latter explanation is highly attractive
because it also implies that different DHPR-RyR1 coupling
domains could trigger SR Ca2 release perhaps indepen-
dently of each other. Such a model could provide a basis for
understanding the phenotype of the 671–690/724–743
construct and the fact that the 720–765 region is function-
ally unique.
The mechanism by which EC coupling is eliminated by
removal of 1S 720–765 and recovered by removal of 1S
720–765 and 1S 671–690 is reminiscent of the electrostatic
interactions that hold the voltage sensor of the Shaker K
channel in a functional state (Papazian et al., 1995). This study
showed that some charge neutralization mutations in the S4
transmembrane segment block protein folding. In these cases,
channel function can be rescued by a second charge neutral-
ization in S2 or S3. The functional rescue by double mutations
suggested that S4 forms a strong network of local electrostatic
charges with other transmembrane domains. The observation
in the Shaker K channel is directly applicable to the II-III
loop, which contains several loci of electrostatic charge within
1S 671–690 and 1S 720–765 and also outside these two
regions. For example, D744DEEDE749 could form a lattice of
negative electrostatic charges stabilized by a lattice of positive
charges provided by R681KRRK685 (see Fig. 1 A). Removal of
1S 720–765 would thus require removal of 1S 671–690 for
maintenance of II-III loop stability. The same example would
explain why the EC coupling loss produced by 724–743,
which does not remove D744DEEDE748, cannot be rescued by
further deletion of 1S 671–690. However, this model would
not explain why 671–690 alone does not disrupt EC cou-
pling. It could be that D744DEEDE749 or other charged resi-
dues in the 720–765 region can be equally well-stabilized by
charges inside and outside the 671–690 region. A study of
charge-charge interactions in the II-III loop by mutagenesis
and functional expression is clearly required to provide an
explanation consistent with all results.
Potential EC coupling domains outside the II-III loop have
been identified in the carboxyl terminus of 1S and the car-
boxyl terminus of the 1a subunit of the DHPR. The carboxyl
terminus of 1S binds to RyR1, inhibits RyR1 channels incor-
porated in planar bilayers, and participates in targeting the
DHPR to junctions containing RyR1 (Slavik et al., 1997;
Proenza et al., 2000b; Flucher et al., 2000; Morales et al.,
2001). DHPR 1 is critical for expression of Ca2 current,
charge movements, Ca2 transients, and Ca2 sparks of cor-
rect morphology (Beurg et al., 1999a, b; Conklin et al., 1999).
Additional observations identified the participation of the C-
termini of 1a in EC coupling under conditions in which the
density of DHPR voltage sensors expressed in the plasma
membrane was not a limiting factor (Beurg et al., 1999b;
Sheridan et al., 2001). Whether these regions contribute to EC
coupling in the absence of the 1S 720–765 region of the II-III
loop remains an attractive possibility. Finally, it is important to
point out that although the fluorescence signal generated by
671–690/720–765 is small, this result cannot be taken as
an argument favoring the notion that the bulk of the EC
coupling is initiated by the II-III loop and that a minor com-
ponent is initiated outside of the II-III loop. A previous report
indicates that 80% of the EC coupling fluorescence signal
can also be eliminated, under conditions of normal charge
movement, by deletions within the DHPR 1a subunit in the
context of an otherwise wild-type DHPR (Beurg et al., 1999b;
Sheridan et al., 2001). Hence, the output signal leaving the
DHPR receives contributions from more than one subunit and,
by nature, is nonadditive. The relative contribution to EC
coupling of different domains within the DHPR is a challeng-
ing issue that needs to be addressed in the future.
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